Skip to content

McKesson MCK Free cash flow

Free cash flow at other companies

Eli Lilly logo
Eli LillyLLY
$3.01B+1,828%
Cardinal Health logo
Cardinal HealthCAH
$1.68B-40.0%
Cencora logo
CencoraCOR
-$2.42B+14.2%
AbbVie logo
AbbVieABBV
$3.56B+155%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
-$34.92M-507%
Viatris logo
ViatrisVTRS

Other financials

Income statement

See full
Revenue$96.3B+6.0%
Gross profit$4.0B+11.1%
Operating income$2.2B+35.1%
Net income$1.7B+33.5%
EPS (diluted)$13.65+37.6%

Balance sheet

See full
Cash & equivalents$4.0B-33.3%
Total debt$2.3B-74.2%
Total equity-$2.2B-4.7%
Total assets$82.3B+9.6%

Cash flow

See full
Operating cash flow$3.4B-55.8%
CapEx$111.0M-34.3%

Valuation

See full
Market cap$89.43B-0.8%
Enterprise value$87.73B-5.7%
P/E18.8×-8.6×
P/S0.2×0.0×

Profitability

See full
Gross margin3.6%-0.1pp
Operating margin1.5%+0.3pp
Net margin1.2%+0.3pp
FCF margin1.4%-0.1pp

Returns & leverage

See full
Return on equity36%
Debt / equity
Current ratio0.9×0.0×

Where this comes from

Calculated from McKesson’s reported figures.

The official record: McKesson’s 10-K, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about McKesson's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is McKesson's free cash flow?
McKesson (MCK) reported free cash flow of $3.31B in Q1 2026.
How has McKesson's free cash flow changed year-over-year?
McKesson's free cash flow decreased by 56.3% year-over-year, from $7.58B to $3.31B.
What is the long-term trend for McKesson's free cash flow?
Over 3 years (2022 to 2026), McKesson's free cash flow has grown at a 12.2% compound annual growth rate (CAGR), from $4.05B to $5.72B.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.